A series of 7 unclassified uterine neoplasms expressing S100 and SOX10, lacking gene fusions and harboring an activating ERBB2 (HER2) mutation at codon 777 were presented in an abstract form at the USCAP annual meeting (Los Angeles, 2023) [14]. The gene discussed is ERBB2; the disease is tumor of uterus.